DMKJ
LGND icon

David M. Knott Jr’s Ligand Pharmaceuticals LGND Stock Holding History

David M. Knott Jr’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-85,000
Closed -$7.16M – 99
2024
Q2 		$7.16M Sell
85,000
-30,000
-26% -$2.39M 2.86% 6
2024
Q1 		$8.41M Hold
115,000
– – 2.97% 6
2023
Q4 		$8.21M Hold
115,000
– – 3.14% 8
2023
Q3 		$6.89M Hold
115,000
– – 2.63% 7
2023
Q2 		$8.29M Hold
115,000
– – 3.3% 7
2023
Q1 		$8.46M Hold
115,000
– – 3.32% 7
2022
Q4 		$7.68M Sell
115,000
-69,345
-38% -$4.51M 2.9% 7
2022
Q3 		$9.9M Hold
184,345
– – 4.17% 5
2022
Q2 		$10.3M Hold
184,345
– – 4.31% 5
2022
Q1 		$12.9M Buy
184,345
+64,120
+53% +$4.65M 4.12% 5
2021
Q4 		$11.6M Buy
+120,225
New +$11.1M 3.93% 5

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

David M. Knott Jr's LGND Position: Q3 2024 in Review

David M. Knott Jr sold out of Ligand Pharmaceuticals (LGND) in Q3 2024, closing a stake of 85,000 shares — an estimated $7.16M sold.

David M. Knott Jr first reported a position in LGND in Q4 2021 and held it in 11 quarters. The position peaked at $12.9M in Q1 2022. 243 funds tracked by Wall St. Rank hold LGND as of Q3 2024.

  • David M. Knott Jr reported no remaining Ligand Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • David M. Knott Jr sold 85,000 Ligand Pharmaceuticals shares in Q3 2024, an estimated $7.16M.
  • David M. Knott Jr first reported a position in Ligand Pharmaceuticals in Q4 2021 and held it in 11 quarters.
  • David M. Knott Jr's Ligand Pharmaceuticals position peaked at $12.9M in Q1 2022.
  • 243 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2024.

Based on David M. Knott Jr's 13F filing for Q3 2024, filed 13 Nov 2024.